Analysts have been eager to weigh in on the Financial sector with new ratings on Jones Lang Lasalle (JLL – Research Report), Ventas (VTR – Research Report) and Claros Mortgage Trust, Inc. (CMTG – Research Report).
Jones Lang Lasalle (JLL)
J.P. Morgan analyst Anthony Paolone maintained a Buy rating on Jones Lang Lasalle on November 10 and set a price target of $214.00. The company’s shares closed last Friday at $165.28.
According to TipRanks.com, Paolone is a 4-star analyst with an average return of
Currently, the analyst consensus on Jones Lang Lasalle is a Moderate Buy with an average price target of $218.75, representing a 34.0% upside. In a report issued on November 3, Raymond James also maintained a Buy rating on the stock with a $243.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
Ventas (VTR)
In a report issued on November 11, Michael Mueller from J.P. Morgan maintained a Hold rating on Ventas, with a price target of $48.00. The company’s shares closed last Friday at $45.31.
According to TipRanks.com, Mueller is a 2-star analyst with an average return of
Currently, the analyst consensus on Ventas is a Moderate Buy with an average price target of $51.25, implying a 13.8% upside from current levels. In a report issued on November 1, Morgan Stanley also maintained a Hold rating on the stock with a $44.50 price target.
Claros Mortgage Trust, Inc. (CMTG)
J.P. Morgan analyst Richard Shane maintained a Sell rating on Claros Mortgage Trust, Inc. on November 11 and set a price target of $16.50. The company’s shares closed last Friday at $18.00.
According to TipRanks.com, Shane is a 5-star analyst with an average return of
Claros Mortgage Trust, Inc. has an analyst consensus of Hold, with a price target consensus of $17.75.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on JLL:
- JP Morgan (NYSE:JPM) Takes a Prudent Approach to Leveraged Deals
- Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (IQV), TG Therapeutics (TGTX) and Gossamer Bio (GOSS)
- OraSure Technologies to Present at Stephens Annual Investment Conference
- Gilat Presents Strong Growth and Results for Third Quarter 2022
- BrainStorm Cell Therapeutics Announces Third Quarter 2022 Financial Results and Provides a Corporate Update